School personnel information


Kiyohara Eiji


Skin Cancer, Immunotherapy, cutaneous lymphoma



Organization 【 display / non-display

  • 2014.04.01 - 2020.09.30, Graduate School of Medicine, Assistant Professor

  • 2020.10.01 - , Division of Medicine, Graduate School of Medicine, Associate Professor

Education 【 display / non-display

Osaka University Graduate School, Division of Medical Sciences  Completed 2011.11

Research topics 【 display / non-display

  • Dermatology-related


Academic Papers 【 display / non-display

  • A rare case of small bowel intussusception due to metastatic malignant melanoma, Yuma Hanaoka, et al., Journal of Cosmetics, Dermatological Sciences and Applications,9, 107-112, 2019.05, Papers

  • Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial., Kim YH et al., Lancet Oncology,19(9):1192-1204, 2018.09, Papers

  • Novel autoantibody against the β2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers., Arase N, Tanimura K et al., The British Journal of Dermatology,178(1):272-275, 2018.01, Papers

  • P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway, Wang J, Hirose H, Du G, Chong K, Kiyohara E, Witz IP, Hoon DSB, Cancer Letter,407:66-75., 2017.10, Papers

  • Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient., Tanaka A, et al, Journal of Dermatology,44(6):727-728, 2017.06, Papers

display all >>